Page 1 | Search Results | Diabetes | American Diabetes Association

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Glucagon Receptor Antagonist–Stimulated α-Cell Proliferation Is Severely Restricted With Advanced Age

Carol J. Lam, Matthew M. Rankin, Kourtney B. King, Melinda C. Wang, Brian C. Shook, Jake A. Kushner

Diabetes 2019;68(5):963–974

https://doi.org/10.2337/db18-1293

Published: 04 March 2019

View article titled, Glucagon Receptor Antagonist–Stimulated α-Cell Proliferation Is Severely Restricted With Advanced Age

Includes: Supplementary data

Journal Articles

Low-Level Insulin Content Within Abundant Non-β Islet Endocrine Cells in Long-standing Type 1 Diabetes

Carol J. Lam, Anirudha Chatterjee, Emily Shen, Aaron R. Cox, Jake A. Kushner

Diabetes 2019;68(3):598–608

https://doi.org/10.2337/db18-0305

Published: 14 December 2018

View article titled, Low-Level Insulin Content Within Abundant Non-β Islet Endocrine Cells in Long-standing Type 1 Diabetes

Includes: Supplementary data

Meeting Abstracts

Increased Time-in-Range with Sotagliflozin as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes as Demonstrated by 24-Week Continuous Glucose Monitoring (inTandem1, inTandem2)

THOMAS DANNE, BERTRAND CARIOU, JOHN B. BUSE, SATISH K. GARG, JULIO ROSENSTOCK, PHILLIP L. BANKS, JAKE A. KUSHNER, DARREN K. MCGUIRE, ANNE L. PETERS, SANGEETA SAWHNEY, PAUL STRUMPH

Diabetes 2018;67(Supplement_1):1179-P

https://doi.org/10.2337/db18-1179-P

Published: 01 July 2018

View article titled, Increased Time-in-Range with Sotagliflozin as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes as Demonstrated by 24-Week Continuous Glucose Monitoring (inTandem1, inTandem2)

Meeting Abstracts

Fifty-Two-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes (The European inTandem2 Study)

THOMAS DANNE, BERTRAND CARIOU, PHILLIP L. BANKS, MICHAEL BRANDLE, HELMUT BRATH, EDWARD FRANEK, JAKE A. KUSHNER, PABLO LAPUERTA, DARREN K. MCGUIRE, ANNE L. PETERS, SANGEETA SAWHNEY, PAUL STRUMPH

Diabetes 2018;67(Supplement_1):1122-P

https://doi.org/10.2337/db18-1122-P

Published: 01 July 2018

View article titled, Fifty-Two-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes (The European inTandem2 Study)

Meeting Abstracts

Fifty-Two-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes (inTandem1)

JOHN B. BUSE, SATISH K. GARG, JULIO ROSENSTOCK, TIMOTHY S. BAILEY, PHILLIP L. BANKS, BRUCE W. BODE, THOMAS DANNE, JAKE A. KUSHNER, WENDY LANE, PABLO LAPUERTA, DARREN K. MCGUIRE, ANNE L. PETERS, JOHN H. REED, SANGEETA SAWHNEY, PAUL STRUMPH

Diabetes 2018;67(Supplement_1):212-OR

https://doi.org/10.2337/db18-212-OR

Published: 01 July 2018

View article titled, Fifty-Two-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes (inTandem1)

Journal Articles

Highly Proliferative α-Cell–Related Islet Endocrine Cells in Human Pancreata

Carol J. Lam, Aaron R. Cox, Daniel R. Jacobson, Matthew M. Rankin, Jake A. Kushner

Diabetes 2018;67(4):674–686

https://doi.org/10.2337/db17-1114

Published: 11 January 2018

View article titled, Highly Proliferative α-Cell–Related Islet Endocrine Cells in Human Pancreata

Includes: Supplementary data

Journal Articles

Area IV Knockout Reveals How Pdx1 Is Regulated in Postnatal β-Cell Development

Aaron R. Cox, Jake A. Kushner

Diabetes 2017;66(11):2738–2740

https://doi.org/10.2337/dbi17-0036

Published: 13 October 2017

View article titled, Area IV Knockout Reveals How Pdx1 Is Regulated in Postnatal β-Cell Development

Journal Articles

Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?

Allison L. O’Kell, Clive Wasserfall, Brian Catchpole, Lucy J. Davison, Rebecka S. Hess, Jake A. Kushner, Mark A. Atkinson

Diabetes 2017;66(6):1443–1452

https://doi.org/10.2337/db16-1551

Published: 15 May 2017

View article titled, Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?

Journal Articles

β-Cells Are Not Generated in Pancreatic Duct Ligation–Induced Injury in Adult Mice

Matthew M. Rankin, Christopher J. Wilbur, Kimberly Rak, Emily J. Shields, Anne Granger, Jake A. Kushner

Diabetes 2013;62(5):1634–1645

https://doi.org/10.2337/db12-0848

Published: 16 April 2013

View article titled, β-Cells Are Not Generated in Pancreatic Duct Ligation–Induced Injury in Adult Mice

Includes: Supplementary data

Journal Articles

Glucose and Inflammation Control Islet Vascular Density and β-Cell Function in NOD Mice: Control of Islet Vasculature and Vascular Endothelial Growth Factor by Glucose

Eitan M. Akirav, Maria-Teresa Baquero, Lynn W. Opare-Addo, Michael Akirav, Eva Galvan, Jake A. Kushner, David L. Rimm, Kevan C. Herold

Diabetes 2011;60(3):876–883

https://doi.org/10.2337/db10-0793

Published: 21 February 2011

View article titled, Glucose and Inflammation Control Islet Vascular Density and β-Cell Function in NOD Mice: <subtitle>Control of Islet Vasculature and Vascular Endothelial Growth Factor by Glucose</subtitle>

Includes: Supplementary data

Journal Articles

Adaptive β-Cell Proliferation Is Severely Restricted With Advanced Age

Matthew M. Rankin, Jake A. Kushner

Diabetes 2009;58(6):1365–1372

https://doi.org/10.2337/db08-1198

Published: 05 March 2009

View article titled, Adaptive β-Cell Proliferation Is Severely Restricted With Advanced Age

Includes: Supplementary data

Journal Articles

β-Cell Mass and Type 1 Diabetes: Going, Going, Gone?

Eitan Akirav, Jake A. Kushner, Kevan C. Herold

Diabetes 2008;57(11):2883–2888

https://doi.org/10.2337/db07-1817

Published: 01 November 2008

View article titled, β-Cell Mass and Type 1 Diabetes: <subtitle>Going, Going, Gone?</subtitle>

Journal Articles

Effects of Autoimmunity and Immune Therapy on β-Cell Turnover in Type 1 Diabetes

Nicole A. Sherry, Jake A. Kushner, Mariela Glandt, Tadahiro Kitamura, Anne-Marie B. Brillantes, Kevan C. Herold

Diabetes 2006;55(12):3238–3245

https://doi.org/10.2337/db05-1034

Published: 01 December 2006

View article titled, Effects of Autoimmunity and Immune Therapy on β-Cell Turnover in Type 1 Diabetes

Journal Articles

Very Slow Turnover of β-Cells in Aged Adult Mice

Monica Teta, Simon Y. Long, Lynn M. Wartschow, Matthew M. Rankin, Jake A. Kushner

Diabetes 2005;54(9):2557–2567

https://doi.org/10.2337/diabetes.54.9.2557

Published: 01 September 2005

View article titled, Very Slow Turnover of β-Cells in Aged Adult Mice

Journal Articles

Islet-Sparing Effects of Protein Tyrosine Phosphatase-1b Deficiency Delays Onset of Diabetes in IRS2 Knockout Mice

Jake A. Kushner, Fawaz G. Haj, Lori D. Klaman, Matthew A. Dow, Barbara B. Kahn, Benjamin G. Neel, Morris F. White

Diabetes 2004;53(1):61–66

https://doi.org/10.2337/diabetes.53.1.61

Published: 01 January 2004

View article titled, Islet-Sparing Effects of Protein Tyrosine Phosphatase-1b Deficiency Delays Onset of Diabetes in IRS2 Knockout Mice

NARROW

Glucagon Receptor Antagonist–Stimulated α-Cell Proliferation Is Severely Restricted With Advanced Age

Low-Level Insulin Content Within Abundant Non-β Islet Endocrine Cells in Long-standing Type 1 Diabetes

Increased Time-in-Range with Sotagliflozin as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes as Demonstrated by 24-Week Continuous Glucose Monitoring (inTandem1, inTandem2)

Fifty-Two-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes (The European inTandem2 Study)

Fifty-Two-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes (inTandem1)

Highly Proliferative α-Cell–Related Islet Endocrine Cells in Human Pancreata

Area IV Knockout Reveals How Pdx1 Is Regulated in Postnatal β-Cell Development

Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?

β-Cells Are Not Generated in Pancreatic Duct Ligation–Induced Injury in Adult Mice

Glucose and Inflammation Control Islet Vascular Density and β-Cell Function in NOD Mice: Control of Islet Vasculature and Vascular Endothelial Growth Factor by Glucose

Adaptive β-Cell Proliferation Is Severely Restricted With Advanced Age

β-Cell Mass and Type 1 Diabetes: Going, Going, Gone?

Effects of Autoimmunity and Immune Therapy on β-Cell Turnover in Type 1 Diabetes

Very Slow Turnover of β-Cells in Aged Adult Mice

Islet-Sparing Effects of Protein Tyrosine Phosphatase-1b Deficiency Delays Onset of Diabetes in IRS2 Knockout Mice

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only